CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
April 14th 2022, 1:15pm
Discussion on when differentiated thyroid cancer is determined to be iodine-refractory, and how patients should be followed in this setting.
April 14th 2022, 1:00pm
Expert perspectives on the process of surgery and radiation therapy used for less severe cases of differentiated thyroid cancer.
April 7th 2022, 1:15pm
Jim Lesniak shares his experience of receiving a diagnosis of and being treated for differentiated thyroid cancer.
April 7th 2022, 1:00pm
Considerations for the role of patient advocacy groups and patient-to-patient education in the differentiated thyroid cancer journey.
April 5th 2022, 7:00pm
Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.
March 31st 2022, 1:20pm
Expert perspectives on the broad management of differentiated thyroid cancer, including surgery, radiation treatment, and systemic therapy.
March 31st 2022, 1:00pm
Health care specialists provide an overview on the nature of differentiated thyroid cancer and discuss subtypes of disease that patients may present with.
March 22nd 2022, 7:00pm
Although certain cancer treatments have been linked to an increased risk of a secondary cancer years later, an expert notes there are no genetic or pathologic studies that prove the association between new and previous cancers.
March 2nd 2022, 4:00pm
Guidelines for the treatment of patients with brain metastases is moving from whole brain radiation therapy to less toxic treatment options to potentially improve care and increase survival.
February 4th 2022, 10:00pm
After four years of additional follow-up, survival continued to improve and side effects remained tolerable in patients with anaplastic thyroid cancer receiving Tafinlar plus Mekinist.
Diagnosis Day: What I Felt, What I Learned
How Survivorship Differs for Men With Metastatic Prostate Cancer
Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer
Saying Goodbye to My Sister With Hodgkin Lymphoma